Weight Loss During Topiramate Treatment in a Severely Obese Adolescent with Congenital Adrenal Hyperplasia and Migraine

Youth with classical congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency exhibit an increased prevalence of obesity, early adiposity rebound, and increased abdominal adiposity compared to unaffected youth. Current obesity management in CAH largely focuses on lifestyle modifications...

Full description

Bibliographic Details

Published in:	JCRPE
Main Authors:	Amy Seagroves, Heather M. Ross, Alaina P. Vidmar, Mitchell E. Geffner, William S. Kim, Darryl Hwang, Claudia Borzutzky, Nicole R. Fraga, Mimi S. Kim
Format:	Article
Language:	English
Published:	Pediatric Endocrinology and Diabetes Society 2023-03-01
Subjects:	congenital adrenal hyperplasia topiramate obesity body composition body fat percentage adolescent 21-hydroxylase deficiency
Online Access:	https://jcrpe.org/jvi.aspx?un=JCRPE-92486&volume=15&issue=1